The market for obesity products has blockbuster potential, but it’s proven an elusive target for the medical device industry. The challenging regulatory environment, weak economy, and skittish investors have slowed the number of product launches in recent years, and there have been some high-profile setbacks for several potential weight loss therapies. But now, a "back to basics" movement, focused on understanding the physiological triggers behind obesity rather than simply restricting food intake, hopes to spur development of more effective minimally invasive weight loss solutions.
by Anne Staylor
With its blockbuster potential, the market for obesity products has been an attractive yet somewhat elusive market for the drug and medical device communities. A significant amount of venture capital...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
